Treatment and outcomes of recurrent Wilms tumor

Source: Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: April 15, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Wilms Tumor / Treatment of Wilms Tumor

Patients with recurrent Wilms tumor should consider enrolling in phase I and phase II clinical trials. Other treatment options for recurrent Wilms tumor are discussed below.

Palliative care remains a central focus of management regardless of whether disease-directed therapy is pursued at the time of progression. This ensures that quality of life is maximized while attempting to reduce symptoms and stress related to the terminal illness.

Continue within this section

Prognosis, prognostic factors, and risk categories for recurrent Wilms tumor →Treatment of standard-risk relapsed Wilms tumor →Treatment of high-risk and very high-risk relapsed Wilms tumor →Treatment options under clinical evaluation for recurrent Wilms tumor →

Preserved source evidence · Not medical advice